Search results for "Atrial"

showing 10 items of 564 documents

Safety and efficacy of left atrial appendage occlusion with the ACP or Watchman device guided by intracardiac echocardiography from the left atrium

2021

Abstract Background There is a paucity of randomized data regarding the safety and efficacy of the use of intracardiac echocardiography (ICE) from the left atrium (LA) to guide left atrial appendage occlusion (LAAO) procedures under local anesthesia using either of the available devices. Hypothesis The aim of this study was to compare the efficacy and safety of ICE from the LA with transesophageal echocardiography (TEE) for guidance during transcatheter LAAO procedures. Methods Single‐center, cohort study of patients undergoing LAAO with the Amplatzer Cardiac Plug or Watchman device. Procedures were guided by ICE from the LA with local anesthesia (n = 175) or TEE under general anesthesia (n…

Cardiac Catheterizationmedicine.medical_specialtyIntracardiac echocardiographymedicine.medical_treatmentClinical InvestigationsLeft atriumLeft atrial appendage occlusionpercutaneous occlusionCohort StudiesAtrial FibrillationmedicineHumansAtrial AppendageLocal anesthesiaThrombusUltrasonography Interventionalbusiness.industryICEAmplatzer cardiac plugGeneral Medicinemedicine.diseaseSurgeryCatheterTreatment Outcomemedicine.anatomical_structureEmbolismleft appendagelocal anesthesiaCardiology and Cardiovascular Medicinebusinesshuman activitiesEchocardiography TransesophagealClinical Cardiology
researchProduct

Thrombosis, fracture, and percutaneous removal of a patent foramen ovale closure device 1 month after successful deployment

2010

Several different devices have been developed for the percutaneous closure of interatrial defects and patent foramen ovale. Although the implantation of these devices is both safe and effective, a number of complications, both in the early and the late follow-up, may occur. We describe a case of device fracture manifested early (1 month after implantation) with the formation of massive thrombosis on the right atrial disc. The patient was treated with anticoagulants and the device was percutaneously retrieved. Our images allowed early noninvasive therapy and emphasize the need for echocardiographic follow-up early after implantation. © 2010 Wiley-Liss, Inc.

Cardiac Catheterizationmedicine.medical_specialtyTime FactorsPercutaneousSeptal Occluder DeviceForamen Ovale PatentProsthesis DesignRight atrialmedicineHumansRadiology Nuclear Medicine and imagingDevice Removalbusiness.industryAnticoagulantsThrombosisGeneral MedicineMiddle Agedmedicine.diseaseThrombosisProsthesis FailureSurgeryRadiographyTreatment OutcomePatent foramen ovaleFemaleCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealCatheterization and Cardiovascular Interventions
researchProduct

Physical activity and risk of atrial fibrillation in the general population : meta-analysis of 23 cohort studies involving about 2 million participan…

2021

Regular physical activity is well established to be associated with reduced risk of cardiovascular disease outcomes. Whether physical activity is associated with the future risk of atrial fibrillation (AF) remains a controversy. Using a systematic review and meta-analysis of published observational cohort studies in general populations with at least one-year of follow-up, we aimed to evaluate the association between regular physical activity and the risk of AF. Relevant studies were sought from inception until October 2020 in MEDLINE, Embase, Web of Science, and manual search of relevant articles. Extracted relative risks (RRs) with 95% confidence intervals (CIs) for the maximum versus the …

Cardiac arrhythmiasMalerytmihäiriötEpidemiologyphysical activity030204 cardiovascular system & hematology0302 clinical medicinesystematic reviewRisk FactorsEpidemiologyMedicineatrial fibrillation030212 general & internal medicinekohorttitutkimussystemaattiset kirjallisuuskatsaukseteducation.field_of_studymeta-analyysiriskitekijäteteisvärinäObservational Studies as Topicrisk factorcardiac arrhythmiasMeta-analysisFemaleCohort studyfyysinen aktiivisuusCohort studymedicine.medical_specialtyPopulationMotor ActivityRisk Assessment03 medical and health sciencesInternal medicinecohort studyHumansRisk factoreducationExercisePhysical activitybusiness.industryArrhythmias CardiacAtrial fibrillationConfidence intervalmeta-analysisRelative riskSystematic reviewObservational studyRisk factorbusinessMeta-Analysis
researchProduct

Electrocardiographic Imaging for Atrial Fibrillation: A Perspective From Computer Models and Animal Experiments to Clinical Value

2021

[EN] Electrocardiographic imaging (ECGI) is a technique to reconstruct non-invasively the electrical activity on the heart surface from body-surface potential recordings and geometric information of the torso and the heart. ECGI has shown scientific and clinical value when used to characterize and treat both atrial and ventricular arrhythmias. Regarding atrial fibrillation (AF), the characterization of the electrical propagation and the underlying substrate favoring AF is inherently more challenging than for ventricular arrhythmias, due to the progressive and heterogeneous nature of the disease and its manifestation, the small volume and wall thickness of the atria, and the relatively large…

Cardiac arrhythmiasmedicine.medical_specialtyVOLUME CONDUCTORPhysiologymedicine.medical_treatmentROTORSCatheter ablationReview030204 cardiovascular system & hematologyTECNOLOGIA ELECTRONICA03 medical and health sciencesPERSISTENT0302 clinical medicinePhysiology (medical)Internal medicineMAGNETIC-RESONANCEmedicineQP1-981PULMONARY VEIN ISOLATIONSistema cardiovascularImatges tridimensionals en medicinabusiness.industrySmall volumeECGAF characterizationPerspective (graphical)Electrocardiographic imagingAtrial fibrillationmedicine.diseaseAtrial fibrillationDOMINANT FREQUENCYKey factorsElectrocardiographic imagingClinical valueCardiologyEnginyeria biomèdicaCatheter ablationbusinessWall thicknessTORSO INHOMOGENEITIESINVERSE PROBLEMInverse solutionTreatment guidance030217 neurology & neurosurgery
researchProduct

Association of Global Longitudinal Strain With Clinical Status and Mortality in Patients With Chronic Heart Failure.

2021

IMPORTANCE: Global longitudinal strain (GLS) is an emerging echocardiographic biomarker of cardiac function in heart failure (HF). Evidence from large-scale studies comprehensively investigating GLS for its association with clinical phenotypes and mortality in asymptomatic and symptomatic chronic HF is limited. OBJECTIVE: To assess the factors associated with GLS and its prognostic value in patients with chronic HF. DESIGN, SETTING, AND PARTICIPANTS: The observational, prospective MyoVasc cohort study enrolled 3289 individuals with asymptomatic to symptomatic HF between January 17, 2013, and April 27, 2018. The median follow-up was 3.2 years (interquartile range, 2.0-4.0 years). Participant…

Cardiac function curveMalemedicine.medical_specialty030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicinemedicineHumans030212 general & internal medicineMyocardial infarctionProspective StudiesAgedOriginal InvestigationHeart Failurebusiness.industryHazard ratioPatient AcuityAtrial fibrillationHeartMiddle Agedmedicine.diseasePrognosisEchocardiographyHeart failureFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersCohort studyJAMA cardiology
researchProduct

Iron overload does not potentiate doxorubicin induced cardiotoxicity in vivo in mice and in vitro in cardiomyocytes cell cultures

2013

Background: Doxorubicin (DOX), an anticancer anthracycline, is known to induce serious cardiotoxicity, which is believed to be mediated by oxidative stress and complex interactions with iron. However, the relations between iron metabolism and DOX-induced cardiotoxicity remain a matter of controversy. Methods: Firstly, we used an in vivo murine model of iron overloading (IO) where male C57BL/6 mice received during 3 weeks (D0-D20) a daily dextran-iron injection (15 mg/kg/day.) and then (D21) a single dose of 6 mg/kg DOX. We evaluated cardiac function with echocardiography, myocardial gene's expression, nitro-oxidative stress levels and iron status. Secondly, the anti-proliferative activity o…

Cardiac function curvemedicine.medical_specialtyCardiotoxicityAnthracyclinebusiness.industrymedicine.disease_causeEndocrinologyAtrial natriuretic peptideIn vivoInternal medicinepolycyclic compoundsmedicineDoxorubicinViability assayCardiology and Cardiovascular MedicinebusinessOxidative stressmedicine.drugEuropean Heart Journal
researchProduct

Plasma Hyperosmolality Prolongs QTc Interval and Increases Risk for Atrial Fibrillation in Traumatic Brain Injury Patients

2020

Introduction: Hyperosmotic therapy with mannitol is frequently used for treatment cerebral edema, and 320 mOsm/kg H2O has been recommended as a high limit for therapeutic plasma osmolality. However, plasma hyperosmolality may impair cardiac function, increasing the risk of cardiac events. The aim of this study was to analyze the relation between changes in plasma osmolality and electrocardiographic variables and cardiac arrhythmia in patients treated for isolated traumatic brain injury (iTBI). Methods: Adult iTBI patients requiring mannitol infusion following cerebral edema, and with a Glasgow Coma Score below 8, were included. Plasma osmolality was measured with Osmometr 800 CLG. Spatial Q…

Cardiac function curvemedicine.medical_specialtyTraumatic brain injuryosmolar gapelectrocardiographylcsh:Medicine030204 cardiovascular system & hematologyQT intervalArticleCerebral edema03 medical and health sciences0302 clinical medicineInternal medicinemedicine030212 general & internal medicinecardiovascular diseasesbusiness.industrytraumatic brain injurylcsh:RGlasgow Coma ScaleCardiac arrhythmiaAtrial fibrillationGeneral Medicinemedicine.diseaseplasma osmolalityPlasma osmolalitycardiac arrhythmiasCardiologycardiovascular systembusinessJournal of Clinical Medicine
researchProduct

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right

2020

For almost half a century, cardiac transplant has been the only long-term treatment for patients with end-stage heart failure. Implantable left ventricular assist devices (LVADs) have emerged as a new treatment option for advanced heart failure as destination therapy for patients either too old or not suitable for transplant. A meta-analysis presenting head-to-head comparisons of cardiac transplant versus LVAD as destination therapy (LVAD-DT) found no difference in 1-year mortality rates between LVAD-DT and cardiac transplant (OR 1.49; 95% CI [0.48–4.66]; I2=82.8%). Moreover, a recent subanalysis from the Interagency Registry for Mechanically Assisted Circulatory Support found similar outco…

Cardiac transplantlcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyCardiomyopathy030204 cardiovascular system & hematologyoutcomes03 medical and health sciences0302 clinical medicineInternal medicineleft ventricular assist deviceDiseases of the circulatory (Cardiovascular) systemMedicine030212 general & internal medicineMyocardial infarctionStrokeHeart Failurebusiness.industryMortality rateAtrial fibrillationmedicine.diseaseequipment and supplieslcsh:RC666-701RC666-701Heart failureCirculatory systemCardiologydestination therapyCardiology and Cardiovascular MedicinebusinessDestination therapyEuropean Cardiology Review
researchProduct

Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, str…

2003

Background: the effects of long-term administration of β-blockers on left ventricular (LV) function during exercise in patients with ischemic heart disease (IHD) and idiopathic dilated cardiomyopathy (DCM) are controversial. Patients and methods: patients with stable congestive heart failure (CHF) (New York heart association [NYHA] class II and III) and ejection fraction (EF) ≤0.40 were randomized to metoprolol, 50 mg t.i.d. or placebo for 6 months. Patients were divided into two groups: ischemic heart disease (IHD) and idiopathic dilated cardiomyopathy (DCM). The mean EF was 0.29 in both groups and 92% were taking angiotensin-converting enzyme (ACE) inhibitors. In the IHD group, 84% had su…

Cardiomyopathy DilatedMalemedicine.medical_specialtyTime FactorsAdrenergic beta-AntagonistsMyocardial IschemiaCardiomyopathyRadionuclide angiographyDouble-Blind MethodInternal medicineIdiopathic dilated cardiomyopathymedicineHumanscardiovascular diseasesMyocardial infarctionExerciseMetoprololEjection fractionVentricular Remodelingmedicine.diagnostic_testbusiness.industryMitral Valve InsufficiencyGated Blood-Pool ImagingHeartStroke VolumeAtrial fibrillationMiddle Agedmedicine.diseaseHeart failureExercise TestCardiologyFemaleCardiology and Cardiovascular MedicinebusinessMetoprololmedicine.drugEuropean Journal of Heart Failure
researchProduct

Left atrial strain and left atrial stiffness for early detection of cardiotoxicity in cancer patients

2021

Abstract Background Anti-cancer drugs can cause cardiovascular complications. Left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) are usually used to identify clinical and subclinical cardiotoxicity. Purpose The aim of our study was to assess the addictional role of left atrial reservoir strain (LAS-S) and left atrial stiffness (LASI – the ratio of E/e' to LAS-S) in identifying patients at higher risk of cardiotoxicity. Methods 102 breast cancer patients (median age 53±9.5 years), without cardiovascular diseases, were enrolled before starting chemotherapy. Electrocardiogram and transthoracic echocardiogram (conventional measurements based on EACVI recommendations;…

Cardiotoxicitymedicine.medical_specialtybusiness.industryLeft atriumEarly detectionCancerLeft atrial strainmedicine.diseaseUpper thoracic spineBreast cancermedicine.anatomical_structureLeft atrialInternal medicineCardiologyMedicineCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct